Search
-
The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
(Respiratory Research. vol. 23, n° 1, pp. 214, 2022-08-23)Article de revueOpen access -
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase((R)))
(Antibiotics. vol. 12, n° 5, 2023-04-25)Article de revueOpen access -
Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study
(Neurological Sciences. vol. 43, n° 6, pp. 3759-3768, 2022-06)Article de revueOpen access -
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
(Cancers. vol. 13, n° 23, 2021-12-05)Article de revueOpen access -
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
(Pharmaceuticals (Basel). vol. 16, n° 10, pp. 1420, 2023-10-05)Article de revueOpen access -
Adverse Drug Reaction-Related to Drug Shortage: A Retrospective Study on the French National Pharmacovigilance Database
(British Journal of Clinical Pharmacology. vol. 89, n° 3, pp. 1080-1088, 2023-03)Article de revueOpen access -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueOpen access -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueOpen access -
Analgesic switching in chronic users of dextropropoxyphene in France
(Fundamental & Clinical Pharmacology, 2023-10-21)Article de revueOpen access -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueOpen access